Organovo Holdings, Inc. announces redemption of 2.9 million outstandin... (at lower cost. In addition to numerous s...)

Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants

Date:2/5/2013

at lower cost. In addition to numerous scientific publications, their technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous others. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com.

Safe Harbor Statement
Any statements contained in this press release that does not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including our current report on Form 8-K/A filed on May 11, 2012. We do not undertake to update these forward-looking statements made by us.

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Organovo Holdings Appoints James T. Glover to Board of Directors
2. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
3. Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Organovo Reports Q2 2012 Financial Results, Provides Business Update
5. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
6. Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research
7. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
8. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
9. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
10. InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012
11. InfuSystem Holdings, Inc. Terminates "Poison Pill" Plan

Post Your Comments:

(Date:5/24/2013)... 24, 2013 China Biologic Products, Inc. (Nasdaq: ... integrated plasma-based biopharmaceutical company in China ... from a public announcement issued by Shanghai RAAS Blood ... on Shenzhen Stock Exchange, that on May 21, 2013, ... Chan"), one of the shareholders of the Company, and ...

(Date:5/24/2013)... The potential of the pulmonary ... therapeutic agents has been receiving undeniable attention with the ... promise. The crucial formulation considerations for orally inhaled products ... major role in the efficiency of pulmonary delivery, and ... new formulation techniques and devices in recent years. ...

(Date:5/23/2013)... SAN DIEGO y PARÍS, 24 de ... VOLC ), un destacado desarrollador y fabricante ... para mejorar la diagnosis y tratamiento de la ... resultados preliminares del ensayo ADVISE ( Ad enosine ... tenosis E valuation) II durante la sesión ...

Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2 China Biologic Comments on the Proposed Shanghai RAAS Transaction 3 China Biologic Comments on the Proposed Shanghai RAAS Transaction 4 Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6

[0] China Biologic Comments on the Proposed Shanghai RAAS Transaction [0] Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany [0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2

... (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for ... Key Recent Highlights: Announced positive ... 2 study of Arikace™ (liposomal amikacin for inhalation) in the ... lung infections Added to Russell 3000, Russell 2000, ...

... Systech International®, the recognized global leader in Serialization and ... and manufacturing optimization services company, today announced that VCG ... in Puerto Rico. VCG now has the ability to ... customer-base in region. "We are thrilled ...

Cached Medicine Technology:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 2 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 3 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 4 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 5 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 6 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 7 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 8 Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 2 Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 3

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico

(Date:5/25/2013)... Texas (PRWEB) May 25, 2013 ... stressful than finals week. Increasingly, they are turning ... stay awake and study. For more on this, ... a drug treatment facility, warns that students who ... finals” are at risk for developing a physical ...

(Date:5/25/2013)... Ayurveda is the traditional medicine ... wisdom of life". While a medical science, its scope enters ... consciousness. Its fundamental philosophy is that disease is the end ... believes that in order to re-establish optimal health, we must ... adopt a life style which brings us back into harmony. ...

(Date:5/25/2013)... Flagstaff, Arizona (PRWEB) May 25, 2013 The ... Rehabilitation Center, their parents, and the B2B staff all came ... While everyone enjoyed an array of Indian Cuisine, the residents ... the company, for helping them on their road to recovery, ... started the Drug and Alcohol center in 2010 after realizing ...

(Date:5/25/2013)... http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , Resource4thePeople is ... of a jury's award of $6.5 million in damages ... the country over allegations that the diabetes drug Actos ... The judge in the case ruled that the man's ... was caused by the medication.** , Bloomberg News in ...

(Date:5/25/2013)... 25, 2013 AdvantaClean of Pikes Peak ... services for a healthy home and business in Colorado ... damage , mold inspections, mold testing, mold removal ... and coil cleaning. , With over 120 offices nationwide, ... industry offering a full suite of services for commercial, ...

Breaking Medicine News(10 mins):Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2 Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2 Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 2 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 3 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 4

[0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals [0] Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes [0] Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary [0] Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases [0] Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area

... Grants New Indication for Bothersome Vaginal Symptom Associated,With ... estrogens) Vaginal Cream 0.5 g has been approved ... a new indication and a new less,frequent twice-weekly ... (painful sexual intercourse) announced Wyeth,Pharmaceuticals, a division of ...

... from patients with lung cancer and examining them under ... utilized to better tailor the chemotherapy treatments to improve ... according to a study presented at the 2008 Chicago ... IASLC and the University of Chicago., Cancer researchers have ...

... tumors of African-American non-small cell lung cancer patients are ... of the epidermal growth factor receptor (EGFR) gene and ... a study presented at the 2008 Chicago Multidisciplinary Symposium ... the University of Chicago., These genetic factors have been ...

... are one milliard of a metre in size are ... materials. There are also significant amounts of nanoparticles in ... their health effects, because only a very small portion ... and safety risks. Nanoparticles have even been dubbed the ...

... http://www.HealthCentral.com ) the leading collection of condition-specific,consumer ... a,broad initiative to sell advertising for any ... partners on a,non-exclusive basis and not require ... party rankings., "We are changing the ...

... those shoppers who,wake up at 4am on Black Friday? Not ... is important not to disturb your circadian rhythm and to ... body,operates better on a good night,s sleep which is why ... the day after Thanksgiving.", SSA retailers nationwide have an ...

Cached Medicine News:Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 2 Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 3 Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 4 Health News:Research demonstrates differing genetic makeup of lung cancer in African-American patients 2 Health News:Nanoparticles trigger cell death? 2 Health News:HealthCentral Announces New Condition-Specific Ad Service to Offer Marketers the Highest Qualified Audiences 2 Health News:Don't Disturb Your Circadian Rhythm This Black Friday 'Sleep In, Nap Later,' says Specialty Sleep Association 2

FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse Tissue analyses indicate survival benefits for some lung cancer patients Research demonstrates differing genetic makeup of lung cancer in African-American patients Nanoparticles trigger cell death?HealthCentral Announces New Condition-Specific Ad Service to Offer Marketers the Highest Qualified Audiences Don't Disturb Your Circadian Rhythm This Black Friday 'Sleep In, Nap Later,' says Specialty Sleep Association

The K-ASSAY Fibrinogen Control is an assayed quality control material intended for use in monitoring the accuracy and precision of the quantitative determination of fibrinogen....

The K-ASSAY Anti-Streptolysin O Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifyi...

Eppendorf expands its line of benchtop microcentrifuges with the 5418. This easy-to-use microcentrifuge features a certified aerosol-tight rotor and a unique, contoured rotor bowl design to reduce no...

... Directigen EZ Flu A+B test is a ... qualitative detection of influenza A and B ... swabs of symptomatic patients. The Directigen EZ ... such that influenza A viral antigens can ...

Medicine Products:

Fibrinogen Control ASO Control Microcentrifuge Model 5418 Directigen EZ Flu A+B Test Kit